NCT06087601View on ClinicalTrials.gov

The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis.

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

January 10, 2025

Study Completion Date

January 14, 2025

Conditions
Osteo Arthritis KneeOsteoarthritis
Interventions
DRUG

0.9% Sodium chloride

us-guided bilateral genicular nerves sham block with 0,5ml 0,9% normal saline

DRUG

95% ethanol

us-guided bilateral genicular nerves neurolysis with 0,5ml 95% ethanol

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06087601 - The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis. | Biotech Hunter | Biotech Hunter